Cucumber Recall Update As FDA Awards Highest Risk Level
The impacted products have now been given a Class I risk classification by the U.S. Food and Drug Administration.
Pharma giant seeks to join lawsuit against FDA over weight loss drugs
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...
Oyster Recall Sparks Fourth Warning by FDA Over Norovirus Fears
The FDA has issued an urgent recall for shellstock oysters harvested last month in Washington state's Hammersley Inlet.
The FDA’s Evolving Role in Public Health
A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...
FDA testing aged raw cow’s milk cheese for bird flu
The Food and Drug Administration (FDA) will begin collecting samples of raw cow’s milk cheese from across the U.S. to test ...
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...
STAT1h
Trump’s FDA transition team takes shape with former Hahn adviser, courts top Capitol Hill aide
Trump's staff is laying the groundwork to prepare for a new FDA commissioner and make their mark at the agency.
FOX 5 Atlanta on MSN5h
FDA issues warning to vets over pet pain drug Librela after deaths reported
After thousands of complaints about complications, the FDA has issued an open letter to veterinarians to be alert to serious ...
medtechdive4h
FDA closes 2024 with string of early alerts on device safety risks
Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.
FiercePharma2h
Novo asks FDA to put kibosh on Victoza compounding amid GLP-1 outsourcing row
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies to produce Victoza, also known as liraglutide, following a proposal by the ...
Targeted Oncology5h
FDA’s December 2024 Oncology Approvals and Designations
On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) in metastatic ...
medtechdive5h
FDA-commissioned review finds no safety concerns linked to tampons
Officials commissioned the independent review in September in response to a study that found tampons may expose users to metals.